Clinical trials in Park Ridge, IL

24 recruiting studies have a site in or near Park Ridge, IL, Illinois.

Top conditions here

All conditions

Showing 24 of 24 studies

RecruitingPhase 3NCT04267848

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Sponsor: National Cancer Institute (NCI)

Alton, IL · Aurora, IL · Barrington, IL · +1147 more sites

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Chicago, IL · Oak Lawn, IL · +112 more sites

RecruitingPhase 3NCT06935370

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Sponsor: Boehringer Ingelheim

Arlington Heights, IL · Hazel Crest, IL · Libertyville, IL · +86 more sites

RecruitingPhase 3NCT06405087

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Sponsor: Takeda

Park Ridge, IL · +12 more sites

RecruitingPhase not listedNCT05334069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Sponsor: Alliance for Clinical Trials in Oncology

Alton, IL · Aurora, IL · +744 more sites

RecruitingPhase 2 / Phase 3NCT05076175

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Sponsor: Bristol-Myers Squibb

Park Ridge, IL · +35 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Chicago, IL · +183 more sites

RecruitingPhase 3NCT06677060

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Sponsor: AstraZeneca

Champaign, IL · Chicago, IL · +195 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Alton, IL · Aurora, IL · +1223 more sites

RecruitingPhase not listedNCT07118306

COPD Exacerbation Follow Up

Sponsor: Viz.ai, Inc.

Park Ridge, IL · +4 more sites

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Chicago, IL · +161 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Aurora, IL · Barrington, IL · +825 more sites

RecruitingPhase 3NCT06100289

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Sponsor: Takeda

Park Ridge, IL · +13 more sites

RecruitingPhase 2 / Phase 3NCT05552157

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Sponsor: Washington University School of Medicine

Park Ridge, IL · +12 more sites

RecruitingPhase 2 / Phase 3NCT06647498

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Sponsor: Washington University School of Medicine

Park Ridge, IL · +12 more sites

RecruitingPhase 2NCT05642572

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network

Barrington, IL · Bloomington, IL · Canton, IL · +451 more sites

RecruitingPhase 2 / Phase 3NCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Sponsor: SWOG Cancer Research Network

Alton, IL · Aurora, IL · +1226 more sites

RecruitingPhase not listedNCT04165109

Trial-Ready Cohort-Down Syndrome (TRC-DS)

Sponsor: University of Southern California

Park Ridge, IL · +17 more sites

RecruitingPhase 3NCT05442567

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Sponsor: Takeda

Park Ridge, IL · +21 more sites

RecruitingPhase 3NCT04779320

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Sponsor: Takeda

Park Ridge, IL · +21 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Alton, IL · Aurora, IL · +809 more sites

RecruitingPhase not listedNCT06073431

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Sponsor: University of Rochester

Alton, IL · Barrington, IL · Bloomington, IL · +222 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Alton, IL · Aurora, IL · +952 more sites

Not yet recruitingNot applicableNCT07809984

Prevention of Oral Mucositis in Adults in With Hematologic Malignancy

Sponsor: Wake Forest University Health Sciences

Oak Lawn, IL · Park Ridge, IL · +1 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.